Figtree Pharmacy, a Mumbai-based startup, has secured seed funding from AJVC Fund and other investors, marking a significant step in its growth trajectory. The funding aims to bolster Figtree’s logistics, enhance its technology infrastructure, launch private-label medicines, and expand its store operations. This development is crucial as it underscores the rising trend of hyperlocal pharmacy models in India’s bustling pharmaceutical sector.
### Figtree Pharmacy’s Unique Approach
Founded in 2025 by Adrit Chaturvedi, a former healthcare analyst at Nomura, and Yatin Sharma of Flipspaces, Figtree Pharmacy is carving a niche with its neighbourhood-centric pharmacy model. Unlike traditional large-format pharmacies with extensive product ranges, Figtree focuses on smaller, more agile storefronts that cater to hyperlocal demands. Currently, the startup operates four locations in Mumbai and Delhi, with an imminent launch in Greater Kailash II. Its strategy is paying off, as evidenced by more than 90% of its revenue stemming from repeat customers and an average order value exceeding Rs 1,000.
### Funding Environment and Competition
The current funding environment in India is witnessing robust activity in the healthcare and pharmacy sectors, with investors keen on tapping into innovative models that promise scalability and sustainability. AJVC Fund, led by Aviral Bhatnagar, is actively expanding its portfolio with investments in emerging startups like Bubble Me, Finanjo, and Mindcase, to name a few. Figtree’s seed funding aligns with this trend, showcasing investor confidence in hyperlocal business models that address the unique needs of urban consumers.
In the competitive landscape, Figtree faces rivals such as 1mg, Netmeds, and PharmEasy, which have established strong online and offline presences. However, Figtree’s emphasis on community-focused services and the physical proximity of its stores provide a distinctive edge in terms of customer loyalty and service personalization.
### Implications for India’s Startup Ecosystem
Figtree Pharmacy’s growth trajectory highlights a broader shift in India’s startup ecosystem towards localized and specialized service offerings. By prioritizing hyperlocal needs and developing a robust logistics and technology backbone, Figtree is setting a precedent for other startups aiming to penetrate traditional sectors with innovative models. This approach not only enhances consumer experience but also presents scalable opportunities for other entrepreneurs in the retail and healthcare domains.
The success of Figtree’s model could inspire new entrants to explore niche markets with tailored solutions, potentially leading to a more diversified startup landscape. Investors may also become more inclined to support startups that exhibit a clear understanding of local market dynamics and consumer preferences.
As Figtree Pharmacy embarks on its expansion journey, industry observers will be keen to see how the startup leverages its fresh capital to scale operations and maintain its competitive advantage. For founders and investors, the key takeaway is the importance of combining hyperlocal strategies with technology-driven efficiencies. Watching how Figtree navigates its growth phase will offer valuable insights into the scalability of hyperlocal business models in India’s dynamic startup ecosystem.
